rs767146349
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_139076.3(ABRAXAS1):c.272A>T(p.Asn91Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000217 in 1,521,238 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_139076.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ABRAXAS1 | NM_139076.3 | c.272A>T | p.Asn91Ile | missense_variant | Exon 4 of 9 | ENST00000321945.12 | NP_620775.2 | |
ABRAXAS1 | NM_001345962.2 | c.-45-1836A>T | intron_variant | Intron 3 of 7 | NP_001332891.1 | |||
ABRAXAS1 | XR_001741334.3 | n.300A>T | non_coding_transcript_exon_variant | Exon 4 of 9 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000145 AC: 22AN: 152236Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000137 AC: 2AN: 145924Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 78104
GnomAD4 exome AF: 0.00000804 AC: 11AN: 1369002Hom.: 0 Cov.: 26 AF XY: 0.00000592 AC XY: 4AN XY: 675868
GnomAD4 genome AF: 0.000145 AC: 22AN: 152236Hom.: 0 Cov.: 32 AF XY: 0.000121 AC XY: 9AN XY: 74376
ClinVar
Submissions by phenotype
not specified Uncertain:2
The p.N91I variant (also known as c.272A>T), located in coding exon 4 of the FAM175A gene, results from an A to T substitution at nucleotide position 272. The asparagine at codon 91 is replaced by isoleucine, an amino acid with dissimilar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Variant summary: FAM175A c.272A>T (p.Asn91Ile) results in a non-conservative amino acid change located in the MPN domain (IPR037518) of the encoded protein sequence. Three of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 1.4e-05 in 145924 control chromosomes. The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. c.272A>T has been reported in the literature in at least one individual with a personal or family history of Hereditary Breast And Ovarian Cancer Syndrome (Martin_2024). These report(s) do not provide unequivocal conclusions about association of the variant with Hereditary Breast And Ovarian Cancer Syndrome. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publication has been ascertained in the context of this evaluation (PMID: 38566764). ClinVar contains an entry for this variant (Variation ID: 411318). Based on the evidence outlined above, the variant was classified as uncertain significance. -
not provided Uncertain:1
This sequence change replaces asparagine, which is neutral and polar, with isoleucine, which is neutral and non-polar, at codon 91 of the ABRAXAS1 protein (p.Asn91Ile). This variant is present in population databases (rs767146349, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with ABRAXAS1-related conditions. ClinVar contains an entry for this variant (Variation ID: 411318). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt ABRAXAS1 protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at